News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Genes & Cancer | Expression of HOTAIR and MEG3 are negatively associated with H. pylori positive status in gastric cancer patients

Genes & Cancer

November 18, 2022
PRESS RELEASE: A new research paper was published in Genes & Cancer on February 10, 2022, entitled, “Expression of HOTAIR and MEG3 are negatively associated with H. pylori positive status in gastric cancer patients.” continue reading »

Oncotarget | Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas

News

November 17, 2022
PRESS RELEASE: On November 17, 2022, Oncotarget published a new research paper, entitled, “Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas.” continue reading »

Aging | IGF1 gene therapy in middle-aged female rats delays reproductive senescence through its effects on hypothalamic GnRH and kisspeptin neurons

Aging

November 15, 2022
PRESS RELEASE: A new research paper was published as the cover for Aging's Volume 14, Issue 21, entitled, “IGF1 gene therapy in middle-aged female rats delays reproductive senescence through its effects on hypothalamic GnRH and kisspeptin neurons.” continue reading »

Aging | Age-associated changes in microglia activation and Sirtuin-1- chromatin binding patterns

News

November 10, 2022
PRESS RELEASE: A new research paper was published in Aging's Volume 14, Issue 20, entitled, “Age-associated changes in microglia activation and Sirtuin-1- chromatin binding patterns.” continue reading »

Oncotarget | MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

News

November 10, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on November 2, 2022, entitled, “MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway.” continue reading »